North America Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity

  • Product Code:
    RP-ID-10352329
  • Published Date:
    7 Jan 2022
  • Region:
    Regional
  • Pages:
    136
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-26

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2020 Base Year, 2021 Estimated year and Forecast till 2030 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2020 as base year, 2021 as estimated year and forecast to 2030. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. North America bioelectric medicine market is projected to grow by 7.0% annually in the forecast period and reach $15.82 billion by 2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 63 tables and 39 figures, this 136-page report “North America Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Implantable Bioelectric Medicine
o Cardiac Pacemaker
o Implantable Cardioverter Defibrillators (ICD)
o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
o Cochlear Implants
o Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
o Vagus Nerve Stimulators
o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
o Retinal Implants
o Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
o Transcutaneous Electrical Nerve Stimulators
o Transcranial Magnetic Stimulation (TMS)
o Pulsed Electromagnetic Field Therapy
o Other Non-invasive Bioelectric Medicines

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals and Clinics
• Research Institutes
• Individual Users

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)



.

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of North America Market by Product Type 39
3.1 Market Overview by Product Type 39
3.2 Implantable Bioelectric Medicine 41
3.2.1 Cardiac Pacemaker 43
3.2.2 Implantable Cardioverter Defibrillators (ICD) 44
3.2.3 Spinal Cord Stimulators 45
3.2.4 Cochlear Implants 46
3.2.5 Deep Brain Stimulators 47
3.2.6 Vagus Nerve Stimulators 48
3.2.7 Sacral Nerve Stimulators 49
3.2.8 Retinal Implants 50
3.2.9 Other Implantable Bioelectric Medicines 51
3.3 Non-invasive Bioelectric Medicine 52
3.3.1 Transcutaneous Electrical Nerve Stimulators 54
3.3.2 Transcranial Magnetic Stimulation (TMS) 55
3.3.3 Pulsed Electromagnetic Field Therapy 56
3.3.4 Other Non-invasive Bioelectric Medicines 57
4 Segmentation of North America Market by End User 58
4.1 Market Overview by End User 58
4.2 Hospitals and Clinics 60
4.3 Research Institutes 61
4.4 Individual Users 62
5 North America Market 2020-2030 by Country 63
5.1 Overview of North America Market 63
5.2 U.S. 66
5.3 Canada 72
5.4 Mexico 74
6 Competitive Landscape 76
6.1 Overview of Key Vendors 76
6.2 New Product Launch, Partnership, Investment, and M&A 82
6.3 Company Profiles 83
Abbott Laboratories 83
BIOTRONIK SE & Co. KG 86
Boston Scientific Corporation 90
Cochlear Limited 94
electroCore, Inc. 97
Inspire Medical Systems, Inc. 99
LivaNova PLC 101
Medtronic PLC 103
NeuroMetrix, Inc 107
Nevro Corp. 109
Nuvectra Corporation 111
OMRON CORPORATION 113
Pixium Vision 116
Second Sight Medical Products Inc 119
SetPoint Medical 122
Sonova Holding AG 124
St. Jude Medical, Inc. 126
Stimwave LLC 128
7 Investing in North America Market: Risk Assessment and Management 130
7.1 Risk Evaluation of North America Market 130
7.2 Critical Success Factors (CSFs) 133
Related Reports and Products 136

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports